Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: A review of the Food and Drug Administration Adverse Event Reporting System

Derrick J. Stobaugh; Parakkal Deepak; Eli D. Ehrenpreis

doi:10.1007/s00228-012-1416-1

Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: A review of the Food and Drug Administration Adverse Event Reporting System

Derrick J. Stobaugh, Parakkal Deepak, Eli D. Ehrenpreis

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1041-1042
Number of pages	2
Journal	European Journal of Clinical Pharmacology
Volume	69
Issue number	4
DOIs	https://doi.org/10.1007/s00228-012-1416-1
State	Published - Apr 2013

Access to Document

10.1007/s00228-012-1416-1

Cite this

@article{3c2dd78f376a44218688a88f224c31b4,

title = "Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: A review of the Food and Drug Administration Adverse Event Reporting System",

author = "Stobaugh, {Derrick J.} and Parakkal Deepak and Ehrenpreis, {Eli D.}",

year = "2013",

month = apr,

doi = "10.1007/s00228-012-1416-1",

language = "English",

volume = "69",

pages = "1041--1042",

journal = "European Journal of Clinical Pharmacology",

issn = "0031-6970",

number = "4",

}

Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: A review of the Food and Drug Administration Adverse Event Reporting System. / Stobaugh, Derrick J.; Deepak, Parakkal; Ehrenpreis, Eli D.
In: European Journal of Clinical Pharmacology, Vol. 69, No. 4, 04.2013, p. 1041-1042.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne

T2 - A review of the Food and Drug Administration Adverse Event Reporting System

AU - Stobaugh, Derrick J.

AU - Deepak, Parakkal

AU - Ehrenpreis, Eli D.

PY - 2013/4

Y1 - 2013/4

UR - http://www.scopus.com/inward/record.url?scp=84876725054&partnerID=8YFLogxK

U2 - 10.1007/s00228-012-1416-1

DO - 10.1007/s00228-012-1416-1

M3 - Letter

C2 - 23052415

AN - SCOPUS:84876725054

SN - 0031-6970

VL - 69

SP - 1041

EP - 1042

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

IS - 4

ER -

Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: A review of the Food and Drug Administration Adverse Event Reporting System

Access to Document

Other files and links

Cite this